Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.
OpenAI Group PBC today announced plans to acquire Astral Software Inc., a startup with a set of widely used Python development tools.  The terms of the deal were not disclosed. Astral’s development ...
Seriously? Astral's tools aren't even AI-focused, and now they're tied to a company that's losing money hand over fist? Click to expand... I'm guessing that a fair amount of stuff around AI (be it ...